Medicines licensing

Pharmacists advised to check legal status of CBD products before supply or risk indemnity breach

Pharmacists selling or supplying cannabis-based products for medicinal use or cannabidiol-containing products must check the status of the product or risk not being protected by indemnity insurance, the National Pharmacy Association has warned.…

Cannabis trade body will also focus on clinical trials

The Centre for Medicinal Cannabis has announced plans to extend its remit to focus on clinical trials.…

How the pregabalin case has set back drug repurposing

The 2018 Supreme Court verdict on Pfizer’s second patent for Lyrica has drawn attention to the limitations of the current framework for extending the usefulness of existing treatments.…

Pharmacy negotiators urge DHSC to allow pharmacies to trade stock without wholesale licence after Brexit

Pharmacists should be allowed to exchange stocks of medicines to mitigate local medicines shortages after Brexit, pharmacy leaders have said.…

A quick guide to medical cannabis

With medical cannabis now legal in 44 countries around the world, and the UK likely to follow suit, here is what pharmacists need to know.…

Medical cannabis: what will pharmacy’s role be?

How the UK has realised the benefits of medical cannabis and the involvement pharmacists could have in its supply.…

EMA endorses strengthened regulatory measures for valproate

The European Medicines Agency’s Coordination Group for Mutual Recognition and Decentralised Procedures — Human has endorsed strengthened measures to avoid valproate exposure during pregnancy.…

Cities compete to host EMA

The European Medicines Agency (EMA) has assessed the bids of 19 cities that have applied to host its headquarters following the UK’s exit from the European Union in 2019. The final relocation decision will be made by the European Council on 20 November 2017.…

Any form of Brexit will hit UK healthcare, researchers warn

Leaving the EU could profoundly affect medicines licensing and leave the NHS struggling to keep staff, a health policy review published in The Lancet has said.…

Three decades of Viagra

Sildenafil (Viagra) — the first oral drug for erectile dysfunction to hit the market in 1998 — has been prescribed for more than 64 million men worldwide, and may soon be reclassified as a pharmacy medicine in the UK.…